Vancomycin
Back to searchMolecule Structure
Scientific Name
Vancomycin
Description of the Drug
Vancomycin is a glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00512
http://www.drugbank.ca/drugs/DB00512
Brand Name(s)
Not Available
Company Owner(s)
Sagent Pharmaceuticals Inc, Watson Laboratories Inc, Fresenius Kabi Usa Llc, Samson Medical Technologies Llc, Orient Pharma Co Ltd, Lupin Ltd, Azurity Pharmaceuticals Inc, Ani Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Peptidoglycan | MACROMOLECULE | INHIBITOR | CHEMBL3041361 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3177 | ||
| PharmGKB | PA451850 | ||
| Human Metabolome Database | HMDB0014653 | ||
| WDI | VANCOMYCI | ||
| DrugBank | DB00512 | ||
| PubChem: Thomson Pharma | 14842128 | 14842127 | |
| PubChem | 14969 | ||
| LINCS | LSM-45214 | ||
| Nikkaji | J34.275K | ||
| BindingDB | 50335519 | ||
| EPA CompTox Dashboard | DTXSID0042664 | ||
| DrugCentral | 2807 | ||
| Metabolights | MTBLC28001 | ||
| Guide to Pharmacology | 10932 | ||
| GSRS | c0145b5f-0f77-4810-9917-f89115347e45 | ||
| rxnorm | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN | VANCOCIN |
| ChEBI | 28001 |
